Crossmark

Early oral administration of THC:CBD formulations prevent pain-related behaviors without exacerbating paclitaxel-induced changes in weight, locomotion, and anxiety in a rat model of chemotherapy-induced neuropathy

Crossref DOI link: https://doi.org/10.1007/s00213-025-06778-y

Published Online: 2025-03-31

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soriano, Delia

Brumovsky, Pablo Rodolfo

Villar, Marcelo José

Coronel, María Florencia https://orcid.org/0000-0001-7037-5105
Funding

Funding for this research was provided by:

Secretaría de Ciencia y Tecnología (Proyecto 29A)

Agencia Nacional de Promoción Científica y Técnica (PICT 2020-030)

Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 297)

Universidad Austral (O05-PDISR098)
License Information

Text and Data Mining valid from 2025-03-31

Version of Record valid from 2025-03-31
More Information

Article History

Received: 24 October 2024

Accepted: 24 March 2025

First Online: 31 March 2025

Declarations

:

: All procedures were approved by the local Animal Care and Use Committee from Instituto de Investigaciones en Medicina Traslacional (IIMT) CONICET-Universidad Austral, Buenos Aires, Argentina (Assurance number 03/2020 and 04/2020) and were carried out in accordance with all relevant guidelines and regulations.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below